Top Markets
#1 Akedo Akedo +73.50%
#2 MEET48 MEET48 +26.11%
#3 Bitway Bitway +21.76%
#4 VeThor VeThor +21.08%
#5 Power Protocol Power Protocol +17.38%
#6 Tutorial Tutorial +16.23%
#7 Astar Astar +14.86%
#8 龙虾 (Lobster) 龙虾 (Lobster) +12.72%
#9 Falcon Finance Falcon Finance +12.11%
#10 Arbitrum Arbitrum +12.09%
Coin of the day
Akedo Akedo
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Hisse Senetlerindeki Sıralama #37014
Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating... Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating therapies for the acute phase of thrombotic conditions. The company's lead compound, glenzocimab, is a humanized monoclonal antibody fragment specifically designed to target a particular platelet glycoprotein. Currently, Acticor Biotech is advancing two clinical programs, both in Phase II/III, for the registration of treatments for ischemic stroke. Additionally, it is conducting two other Phase II trials concerning significant cardiovascular emergencies, with anticipated clinical data expected from both its ischemic stroke research and studies related to COVID-19 respiratory distress syndrome. Established in 2013, the company operates from its headquarters in Paris, France.
Hisse Fiyatı
$0.25974701
Son senkronizasyon: 2025-01-06
Piyasa Değeri
$2.04M
Değişim (1 gün)
0.74%
Değişim (1 yıl)
0.00%
Ülke
FR
Ticaret Acticor Biotech SAS (ALACT)

Kategori

Healthcare
Acticor Biotech SAS (ALACT) için P/S oranı
September 2026 itibarıyla P/S oranı TTM: 0.00
Acticor Biotech SAS şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/S oranı (TTM) 0.00'dir. 2022 yılının sonunda şirketin P/S oranı 0.00 idi.
Acticor Biotech SAS için P/S oranı geçmişi 2010 - 2026 arası
Her yılın sonunda P/S oranı
Yıl P/S Oranı Değiştir
2026 (TTM) 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 -100.00%
2018 432.73 16,252.85%
2017 2.65 56.77%
2016 1.69 23.03%
2015 1.37 16.08%
2014 1.18 -11.28%
2013 1.33 -13.75%
2012 1.54 -29.62%
2011 2.19 -58.15%
2010 5.24 0.00%
Benzer şirketler veya rakipler için P/S oranı
Şirket P/S Oranı P/S Oranı Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.44 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.01 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.76 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
26.12 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH